- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
Korea Investment CORP Boosts AbbVie Stake by 13.9%
The fund now owns over 1.5 million shares of the pharmaceutical company.
Published on Mar. 8, 2026
Got story updates? Submit your updates here. ›
Korea Investment CORP, a major institutional investor, increased its holdings in AbbVie Inc. (NYSE:ABBV) by 13.9% in the third quarter, according to a recent SEC filing. The fund now owns 1,550,150 shares of the pharmaceutical company's stock, making it one of AbbVie's largest shareholders.
Why it matters
AbbVie is a leading global biopharmaceutical company with a diverse portfolio of specialty medicines. Institutional investors like Korea Investment CORP closely monitor and adjust their positions in major pharmaceutical stocks like AbbVie, which can signal broader market trends and investor sentiment around the company's performance and future prospects.
The details
In its 13F filing, Korea Investment CORP reported that it added 188,587 shares of AbbVie during the third quarter, bringing its total stake to over 1.5 million shares. This represents approximately 0.09% of AbbVie's outstanding shares. The fund's increased investment in AbbVie is likely driven by the company's strong financial results, pipeline of new therapies, and growth potential.
- Korea Investment CORP filed its 13F report for the third quarter of 2026 on March 8, 2026.
The players
Korea Investment CORP
A major South Korean sovereign wealth fund that manages over $200 billion in assets globally.
AbbVie Inc.
A global biopharmaceutical company that develops and commercializes innovative therapies for complex and chronic medical conditions.
The takeaway
Korea Investment CORP's increased stake in AbbVie reflects the fund's confidence in the pharmaceutical company's long-term growth potential. As a major institutional investor, Korea Investment CORP's portfolio moves can provide valuable insights into broader market trends and investor sentiment around leading healthcare stocks.
